Arkolith/Insider Trading/DFFN/Form 4

Cobuzzi Robert Joseph Jr.

President & CEO, DirectorDiffusion Pharmaceuticals Inc. (DFFN) · full profile →Form 4 · filed Mar 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2022Buy(P)5K$0.50$3K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-006871) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML